Drug Database
Back to search

Belgium· BE-AMP-SAM196847-00

Glycophos 20 ml

A sodium glycerophosphate product containing sodium glycerophosphate hydrate, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 9 of our 19 countries.

ATC B05XA14

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedGlycophos 20 mlATCB05XA14REGISTER NO.BE-AMP-SAM196847-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sodium glycerophosphate hydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sodium glycerophosphate is registered in 9 of 19 countries.

Countries holding a registration under ATC B05XA14 (sodium glycerophosphate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search sodium glycerophosphate products by name

Sodium glycerophosphate · ATC B05XA14

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Sodium Glycerophosphate Hydrate
Manufacturer
Fresenius Kabi
Country
Belgium (BE)
ATC code
B05XA14
ATC class
Sodium glycerophosphate
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1433549

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for sodium glycerophosphate.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sodium glycerophosphate against other medicinesHow interaction checks work

Sodium glycerophosphate · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sodium glycerophosphate in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium glycerophosphate products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Glycophos
  • Cyprus · Glycophos
  • Czechia · Sodium Glycerophosphate Fresenius
  • Germany · Natriumglycerophosphat-Ampulle Fresenius
  • Denmark · Glycophos
  • Spain · Glycophos
  • Finland · Glycophos
  • France · Glycerophosphate De Sodium
  • Greece · Glycophos
  • Hungary · Nátrium-Glicerin-Foszfát Fresenius
  • Italy · Glycophos
  • Lithuania · Glycophos
  • Latvia · Glycophos
  • Netherlands · Glycophos
  • Poland · Glycophos
  • Portugal · Glycophos
  • Romania · Glycophos
  • Sweden · Glycophos
  • Slovakia · Sodium Glycerophosphate Fresenius

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a7f375c2-6b5c-4553-b4c0-e143905e55a2
GET /v1/drugs/a7f375c2-6b5c-4553-b4c0-e143905e55a2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Glycophos 20 ml",
  "name_fr": "Glycophos 20 ml",
  "name_nl": "Glycophos 20 ml",
  "amp_code": "SAM196847-00",
  "strengths": [
    "306.1000",
    "216.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Sodium Glycerophosphate Hydrate",
    "Sodium Glycerophosphate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Sodium Glycerophosphate",
  "authorisation_numbers": [
    "BE196847"
  ]
}
API referenceMCP serverPlans

See everything about sodium glycerophosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console